{"name":"Incyte Corporation","slug":"incyte-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNajcyZzVmekh4V1BqRXMwM2ZCeXJRN0VseG1hUDAzWUVDUDJiMk9Pd3k0WExMSDlsYm1ualE1QUVSdUdBWkswRi0wcTU2UHJpN215YjNPMzZXTENNSVJtbzRUalZVN3FoZ0t4MElpWWtQQ0QxY0JxY3RpNHVIWG8wbDBOZVd3QWp1elgzdzdIaW9nTjBxR0g1b2d3eUo5aElEREVn?oc=5","date":"2026-03-25","type":"pipeline","source":"Contract Pharma","summary":"Incyte Appoints Three to Executive Leadership Positions - Contract Pharma","headline":"Incyte Appoints Three to Executive Leadership Positions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPR2w2U1E2NjZFNmgzNkZDS0dSOF9aaVpCM3d4SGhxZDRHdWtneDBldlpjSG1RTnVpcWhHa0FCMjFzMWNOcDM1cmd3VUptTG5hRnFpYjVhdWFyeFN2S0pKOFpucXlSTC1heEFNam9lOGNvYllSZFl4X1JhdlFVRGJBcDV1LTZXUFd3QjRkQ0F6UjFBQQ?oc=5","date":"2026-01-22","type":"deal","source":"Seeking Alpha","summary":"What Investors Should Know Before Buying Incyte Stock (NASDAQ:INCY) - Seeking Alpha","headline":"What Investors Should Know Before Buying Incyte Stock (NASDAQ:INCY)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPZzFKcUxPZUNFcXNLYW9SbWVaV19pMXF5NzhxRFJMbWlhTXptdkFmaWNDOUctQjVnNEItaGdQRFROeFhKV28xZkZ5Z3BobnNhNUI4SklRNXVVOWtXYVhCaXM3c0VoYXd6TWlmbWx5VlRBRmxfdWlYS3JfWkRJMTlsMGJpRDFzWFNteG1KcDZwaG5EblJEZjhzOGxCSjZaUkE?oc=5","date":"2025-11-25","type":"regulatory","source":"Medical Marketing and Media","summary":"Incyte receives the first letter confirming compliance following the FDA’s Untitled Letter spree - Medical Marketing and Media","headline":"Incyte receives the first letter confirming compliance following the FDA’s Untitled Letter spree","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-03","type":"pipeline","source":"Business Wire","summary":"United States Vitiligo Forecast Report 2025: A $320+ Million Market by 2033 Featuring Incyte, BMS, Clinuvel Pharmaceuticals, Astellas Pharma, Baxter, Pfizer, Dr. Reddy's Laboratories - ResearchAndMark","headline":"United States Vitiligo Forecast Report 2025: A $320+ Million Market by 2033 Featuring Incyte, BMS, Clinuvel Pharmaceutic","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-14","type":"pipeline","source":"simplywall.st","summary":"Incyte Corporation's (NASDAQ:INCY) Price Is Right But Growth Is Lacking After Shares Rocket 26% - simplywall.st","headline":"Incyte Corporation's (NASDAQ:INCY) Price Is Right But Growth Is Lacking After Shares Rocket 26%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNYUpQcnBPY21uM1c1RXZJem9YZENValE2QUdILWprM3ZTRDlUR0ZTc1BQUHJGYVF3ZFFJMFp0ZkFNREN3czJ2WDhYajB1T3JwSVg0aHg4RG9XUFh3bTZDY0g2SktwRjZicm1Za1ZucnB5QjNPMEpmM1dMYkw2R1BodkoxQ2pKb3dHSlZ1dWJNZ2h3akQzVWVXcTg3MDlLWWZnZjRadlhxeFhpbWNY?oc=5","date":"2025-08-04","type":"deal","source":"Fierce Pharma","summary":"Incyte's new CEO pledges 'fresh look' at business, outlines dealmaking strategy - Fierce Pharma","headline":"Incyte's new CEO pledges 'fresh look' at business, outlines dealmaking strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOdVBfVHYxaS1ScEhLMXhGLWdnQmhQVndtUG12dVplMi05ZmJRYl94RGxCaUFyNUJLR2Y2VGtjUE40NWp5N0xHQUZ0ZWkyQWwzNEptSDgyemxnOGc2UE0zT3AzanE5MUNuc3p4QnJvOHVXTFNYVlExVUktOUlKYUZNc1g5VTMwQ1l0QTIyVmtBZ1JiWEw3RVU4TTZram9sbkZrS2lmVGlJMDBVYkFieHg0UEV6dw?oc=5","date":"2025-07-15","type":"pipeline","source":"The Pharma Letter","summary":"Sun Pharma reaches settlement with Incyte and launches Leqselvi in USA - The Pharma Letter","headline":"Sun Pharma reaches settlement with Incyte and launches Leqselvi in USA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-07-15","type":"pipeline","source":"The Economic Times","summary":"Sun Pharma shares in focus following US launch of LEQSELVITM, settlement with Incyte Corporation - The Economic Times","headline":"Sun Pharma shares in focus following US launch of LEQSELVITM, settlement with Incyte Corporation","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-14","type":"pipeline","source":"The Hindu","summary":"Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S. - The Hindu","headline":"Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOYzZIaEo2TVlRVW9VamttYmplSWZuS24xbDMtMjhyZ2V4Z3g3UzVSWUF6dzRzV1lRdzdVUGpLMjBxTmkydnFmV25oZFVLb2JDVVVFX0JhTUhKdDhJeFJHZUowNmJyNjloTWhPeDNMUjJGTDYwbmVfYklnYlVpd0NiSWFuWkZmTTE0UTE3anFSUVJMVEJONFhjb0hsd1pQbUlEX28xcGdHaVNSaGVO?oc=5","date":"2025-06-27","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Incyte taps new CEO after longtime leader hangs up his hat - Fierce Biotech","headline":"Chutes & Ladders—Incyte taps new CEO after longtime leader hangs up his hat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPbVRTSDVkRllVMkNqd0poOGlnZjVMZ2h1dDdhUWNRWFlOWTFsaTJEWDVJbjFydnh0WFJvTEhBUHJydkVrdzhOempoM1JnR1NsbUFpazNCaDBibWFrSUYxNEZtaG5ZR3B4WU0wRmdRRmVvVGQwTE1ULXZUUW4zc05BS2F1dVZROUJ0RnE1TFJTOXY?oc=5","date":"2025-06-26","type":"deal","source":"BioPharma Dive","summary":"Incyte replaces CEO Hoppenot with dealmaker Meury - BioPharma Dive","headline":"Incyte replaces CEO Hoppenot with dealmaker Meury","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOSHM1eUctVURXaU5zb09Vc2NXbTRTcjhma2pMc05jVUlBVTJ1dUJJU0dNeU1NV0tPbUlPTHhhUXNfS2c4SlR4NFdYQjd2ZVVOWGJ0MTczNXBoSm1rRXZSQnNxalpadVhWaE1sVDVhSG5zUENiMU5NWncwbEQ5ZFRZdlBVVjRnaVJzOWdEVS0xdy1UeldQSFU1UzBhSEFHaEN2ekhqaHZtZlAxamJpaDBzNDk1SDZUeDBacm5XWDNB?oc=5","date":"2025-06-26","type":"pipeline","source":"Fierce Pharma","summary":"Incyte waves goodbye to longtime CEO Hervé Hoppenot as new appointment raises M&A hopes - Fierce Pharma","headline":"Incyte waves goodbye to longtime CEO Hervé Hoppenot as new appointment raises M&A hopes","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}